Literature DB >> 3049117

Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

J Prandota1, I J Smith, J T Wilson.   

Abstract

The doses of cimetidine recommended differ in children, especially those with cystic fibrosis. These dosage regimens were derived from single-dose pharmacokinetic studies of the drug. Some authors showed, however, that after administration of repeated oral doses of cimetidine in healthy adults and children with cystic fibrosis, the elimination half-life of the drug was markedly prolonged. In view of the ability of cimetidine to inhibit metabolism of other drugs, it is suggested that the parent compound and/or it is metabolite(s) may inhibit its own metabolism during a prolonged course of treatment. Enterohepatic recirculation of the drug and/or its metabolite(s) may also contribute to prolongation of its elimination. One should therefore be cautious in using single-dose pharmacokinetic parameters to calculate repeated dose regimens and expected plasma steady-state concentrations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049117     DOI: 10.1007/BF00615214

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  30 in total

1.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

2.  Intensive hospital monitoring study of intravenous cimetidine.

Authors:  J B Porter; K Beard; A M Walker; D H Lawson; H Jick; G S Kellaway
Journal:  Arch Intern Med       Date:  1986-11

3.  Bioavailability and pharmacokinetics of cimetidine.

Authors:  A Grahnén; C von Bahr; B Lindström; A Rosén
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

4.  Metabolism of drugs by the kidney.

Authors:  M W Anders
Journal:  Kidney Int       Date:  1980-11       Impact factor: 10.612

5.  Cimetidine use in children with cystic fibrosis: inhibition of hepatic drug metabolism.

Authors:  R A Bradbear; R W Shepherd; J Grice; J O'Toole; R K Roberts
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

6.  Bioavailability of cimetidine in man.

Authors:  S S Walkenstein; J W Dubb; W C Randolph; W J Westlake; R M Stote; A P Intoccia
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

7.  Cimetidine potentiation of the hypoprothrombinemic effect of warfarin.

Authors:  B A Silver; W R Bell
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

8.  Cimetidine pharmacokinetics and dosage requirements in children.

Authors:  A Somogyi; M Becker; R Gugler
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

Review 9.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

10.  Long-term cimetidine in children with cystic fibrosis: a randomized double-blind study.

Authors:  M Schöni; R Kraemer; A Ruedeberg; M J Lentze; R C Mordasini; W F Riesen; M P Kläy; E Rossi
Journal:  Pediatr Res       Date:  1984-01       Impact factor: 3.756

View more
  1 in total

Review 1.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.